Replies to post #329451 on NorthWest Biotherapeutics Inc (NWBO)

[kfa670]

I do not believe that updating the clinical trial register right now is a top priority for NWBio

I can't even begin to understand this if it is indeed their strategy. It makes zero since in regard to providing the most up to date and accurate information regarding this trial. For Christ's sake, at the very least it would help convince their shareholder base that they aren't completely incompetent.

I of course have no idea what's involved in updating the site but if I had to guess, it would be as simple as uploading a new document, or providing a new doc to the correct person at the site to upload themselves. A process that could be handled by Les during commercial break at the Big BS Basement Bert and Ernie Show.

Then again, providing and filing the correct paperwork to remain on the OTC is obviously not much of a priority either at times until of course they are REMINDED.

But, I do believe NWBio will update the clinical trial register just before or just after the DCVax-L TLD is released.

I would certainly hope so!! But... Why JUST BEFORE?? What is the point of "just before?"

[MattyWin]

Didn't Innes use the word "clerical" at one point to justify the lack of change to the US trial site? I may be wrong, but if yes, then he may have been implying that the sponsor request was made but the admin folks have yet to update their site (clerical).

[beachhyena]

So ATL tell me why would NWBO not update the clinical website with the endpoints now that the cat is out of the bag so too speak over in Europe. You make absolutely no sense as even DI could accomplish this task in no more than a couple of hours. This very simple task would confirm to the market that the FDA has also bought into these critical new endpoints and would serve to silence the doubters even more. This very simple task would have a huge impact on the share price prior to DL and serve to silence all the shareholders leading up to DL. Literally DI would be fielding 90% less calls if he spent a tiny bit of time confirming the endpoints.